here<\/a> for the publication<\/p>\n","protected":false},"excerpt":{"rendered":"In a scientific publication, Evax presents a newly developed scoring system that shows excellent reliability in the assessment of skin lesions in horses with chronic recurrent urticaria. Both intra-observer and inter-observer reliability and agreement were excellent. It may be a useful tool in clinical trials. Click here for the publication<\/p>\n","protected":false},"author":4,"featured_media":3982,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[21],"tags":[],"dipi_cpt_category":[],"class_list":["post-4075","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"\n
Evax develops new tool for the assessment of chronic recurrent urticaria - EVAX<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evax develops new tool for the assessment of chronic recurrent urticaria - EVAX\" \/>\n<meta property=\"og:description\" content=\"In a scientific publication, Evax presents a newly developed scoring system that shows excellent reliability in the assessment of skin lesions in horses with chronic recurrent urticaria. Both intra-observer and inter-observer reliability and agreement were excellent. It may be a useful tool in clinical trials. Click here for the publication\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/\" \/>\n<meta property=\"og:site_name\" content=\"EVAX\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-21T11:22:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-20T11:45:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.evax.ch\/wp-content\/uploads\/2025\/05\/vde.v36.3.cover_.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"595\" \/>\n\t<meta property=\"og:image:height\" content=\"842\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Widmer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Widmer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\\\/\"},\"author\":{\"name\":\"Widmer\",\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/#\\\/schema\\\/person\\\/08e520e20ff545dad44000172a3d9c80\"},\"headline\":\"Evax develops new tool for the assessment of chronic recurrent urticaria\",\"datePublished\":\"2025-05-21T11:22:04+00:00\",\"dateModified\":\"2025-08-20T11:45:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\\\/\"},\"wordCount\":61,\"image\":{\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.evax.ch\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/vde.v36.3.cover_.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\\\/\",\"url\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\\\/\",\"name\":\"Evax develops new tool for the assessment of chronic recurrent urticaria - EVAX\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.evax.ch\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/vde.v36.3.cover_.jpg\",\"datePublished\":\"2025-05-21T11:22:04+00:00\",\"dateModified\":\"2025-08-20T11:45:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/#\\\/schema\\\/person\\\/08e520e20ff545dad44000172a3d9c80\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.evax.ch\\\/en\\\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.evax.ch\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/vde.v36.3.cover_.jpg\",\"contentUrl\":\"https:\\\/\\\/www.evax.ch\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/vde.v36.3.cover_.jpg\",\"width\":595,\"height\":842},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evax develops new tool for the assessment of chronic recurrent urticaria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/\",\"name\":\"EVAX\",\"description\":\"Pflegeprodukte f\u00fcr Pferde\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/#\\\/schema\\\/person\\\/08e520e20ff545dad44000172a3d9c80\",\"name\":\"Widmer\",\"url\":\"https:\\\/\\\/www.evax.ch\\\/en\\\/author\\\/widmer\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evax develops new tool for the assessment of chronic recurrent urticaria - EVAX","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/","og_locale":"en_US","og_type":"article","og_title":"Evax develops new tool for the assessment of chronic recurrent urticaria - EVAX","og_description":"In a scientific publication, Evax presents a newly developed scoring system that shows excellent reliability in the assessment of skin lesions in horses with chronic recurrent urticaria. Both intra-observer and inter-observer reliability and agreement were excellent. It may be a useful tool in clinical trials. Click here for the publication","og_url":"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/","og_site_name":"EVAX","article_published_time":"2025-05-21T11:22:04+00:00","article_modified_time":"2025-08-20T11:45:35+00:00","og_image":[{"width":595,"height":842,"url":"https:\/\/www.evax.ch\/wp-content\/uploads\/2025\/05\/vde.v36.3.cover_.jpg","type":"image\/jpeg"}],"author":"Widmer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Widmer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/#article","isPartOf":{"@id":"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/"},"author":{"name":"Widmer","@id":"https:\/\/www.evax.ch\/en\/#\/schema\/person\/08e520e20ff545dad44000172a3d9c80"},"headline":"Evax develops new tool for the assessment of chronic recurrent urticaria","datePublished":"2025-05-21T11:22:04+00:00","dateModified":"2025-08-20T11:45:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/"},"wordCount":61,"image":{"@id":"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.evax.ch\/wp-content\/uploads\/2025\/05\/vde.v36.3.cover_.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/","url":"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/","name":"Evax develops new tool for the assessment of chronic recurrent urticaria - EVAX","isPartOf":{"@id":"https:\/\/www.evax.ch\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/#primaryimage"},"image":{"@id":"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.evax.ch\/wp-content\/uploads\/2025\/05\/vde.v36.3.cover_.jpg","datePublished":"2025-05-21T11:22:04+00:00","dateModified":"2025-08-20T11:45:35+00:00","author":{"@id":"https:\/\/www.evax.ch\/en\/#\/schema\/person\/08e520e20ff545dad44000172a3d9c80"},"breadcrumb":{"@id":"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/#primaryimage","url":"https:\/\/www.evax.ch\/wp-content\/uploads\/2025\/05\/vde.v36.3.cover_.jpg","contentUrl":"https:\/\/www.evax.ch\/wp-content\/uploads\/2025\/05\/vde.v36.3.cover_.jpg","width":595,"height":842},{"@type":"BreadcrumbList","@id":"https:\/\/www.evax.ch\/en\/evax-develops-new-tool-for-the-assessment-of-chronic-recurrent-urticaria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.evax.ch\/en\/"},{"@type":"ListItem","position":2,"name":"Evax develops new tool for the assessment of chronic recurrent urticaria"}]},{"@type":"WebSite","@id":"https:\/\/www.evax.ch\/en\/#website","url":"https:\/\/www.evax.ch\/en\/","name":"EVAX","description":"Pflegeprodukte f\u00fcr Pferde","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.evax.ch\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.evax.ch\/en\/#\/schema\/person\/08e520e20ff545dad44000172a3d9c80","name":"Widmer","url":"https:\/\/www.evax.ch\/en\/author\/widmer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.evax.ch\/en\/wp-json\/wp\/v2\/posts\/4075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.evax.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.evax.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.evax.ch\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.evax.ch\/en\/wp-json\/wp\/v2\/comments?post=4075"}],"version-history":[{"count":1,"href":"https:\/\/www.evax.ch\/en\/wp-json\/wp\/v2\/posts\/4075\/revisions"}],"predecessor-version":[{"id":4077,"href":"https:\/\/www.evax.ch\/en\/wp-json\/wp\/v2\/posts\/4075\/revisions\/4077"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.evax.ch\/en\/wp-json\/wp\/v2\/media\/3982"}],"wp:attachment":[{"href":"https:\/\/www.evax.ch\/en\/wp-json\/wp\/v2\/media?parent=4075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.evax.ch\/en\/wp-json\/wp\/v2\/categories?post=4075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.evax.ch\/en\/wp-json\/wp\/v2\/tags?post=4075"},{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/www.evax.ch\/en\/wp-json\/wp\/v2\/dipi_cpt_category?post=4075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}